Clinical Trial Update: Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Alzheimer's Disease

View source ↗

Summary

The clinical trial comparing cellular proteomes from leukocytes of glaucoma patients with those of Alzheimer's disease patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Glaucoma

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Alzheimer's Disease, Glaucoma | Status: WITHDRAWN